JP2019506175A5 - - Google Patents

Download PDF

Info

Publication number
JP2019506175A5
JP2019506175A5 JP2018544819A JP2018544819A JP2019506175A5 JP 2019506175 A5 JP2019506175 A5 JP 2019506175A5 JP 2018544819 A JP2018544819 A JP 2018544819A JP 2018544819 A JP2018544819 A JP 2018544819A JP 2019506175 A5 JP2019506175 A5 JP 2019506175A5
Authority
JP
Japan
Prior art keywords
seq
signal peptide
nucleic acid
ige signal
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018544819A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019506175A (ja
JP7012365B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/019407 external-priority patent/WO2017147458A1/en
Publication of JP2019506175A publication Critical patent/JP2019506175A/ja
Publication of JP2019506175A5 publication Critical patent/JP2019506175A5/ja
Priority to JP2021189383A priority Critical patent/JP7555325B2/ja
Application granted granted Critical
Publication of JP7012365B2 publication Critical patent/JP7012365B2/ja
Priority to JP2024073806A priority patent/JP2024096281A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018544819A 2016-02-25 2017-02-24 ジカウイルスに対する新規のワクチン Active JP7012365B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2021189383A JP7555325B2 (ja) 2016-02-25 2021-11-22 ジカウイルスに対する新規のワクチン
JP2024073806A JP2024096281A (ja) 2016-02-25 2024-04-30 ジカウイルスに対する新規のワクチン

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US201662300030P 2016-02-25 2016-02-25
US62/300,030 2016-02-25
US201662305183P 2016-03-08 2016-03-08
US62/305,183 2016-03-08
US201662396742P 2016-09-19 2016-09-19
US62/396,742 2016-09-19
US201662417100P 2016-11-03 2016-11-03
US62/417,100 2016-11-03
US201762462249P 2017-02-22 2017-02-22
US62/462,249 2017-02-22
PCT/US2017/019407 WO2017147458A1 (en) 2016-02-25 2017-02-24 Novel vaccines against zika virus

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021189383A Division JP7555325B2 (ja) 2016-02-25 2021-11-22 ジカウイルスに対する新規のワクチン

Publications (3)

Publication Number Publication Date
JP2019506175A JP2019506175A (ja) 2019-03-07
JP2019506175A5 true JP2019506175A5 (enExample) 2020-04-02
JP7012365B2 JP7012365B2 (ja) 2022-03-04

Family

ID=59685658

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018544819A Active JP7012365B2 (ja) 2016-02-25 2017-02-24 ジカウイルスに対する新規のワクチン
JP2021189383A Active JP7555325B2 (ja) 2016-02-25 2021-11-22 ジカウイルスに対する新規のワクチン
JP2024073806A Pending JP2024096281A (ja) 2016-02-25 2024-04-30 ジカウイルスに対する新規のワクチン

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021189383A Active JP7555325B2 (ja) 2016-02-25 2021-11-22 ジカウイルスに対する新規のワクチン
JP2024073806A Pending JP2024096281A (ja) 2016-02-25 2024-04-30 ジカウイルスに対する新規のワクチン

Country Status (10)

Country Link
US (2) US11648303B2 (enExample)
EP (1) EP3419660A4 (enExample)
JP (3) JP7012365B2 (enExample)
KR (1) KR20190003471A (enExample)
CN (2) CN109152826B (enExample)
AU (3) AU2017222644B2 (enExample)
BR (1) BR112018017307A2 (enExample)
CA (1) CA3015792A1 (enExample)
MX (2) MX2018010291A (enExample)
WO (1) WO2017147458A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11364292B2 (en) 2015-07-21 2022-06-21 Modernatx, Inc. CHIKV RNA vaccines
MA42502A (fr) 2015-07-21 2018-05-30 Modernatx Inc Vaccins contre une maladie infectieuse
WO2017070624A1 (en) 2015-10-22 2017-04-27 Modernatx, Inc. Tropical disease vaccines
KR20190003471A (ko) 2016-02-25 2019-01-09 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 지카 바이러스에 대항하는 신규한 백신
US11666649B2 (en) * 2016-10-11 2023-06-06 University Of Miami Vectors and vaccine cells for immunity against Zika virus
US11806393B2 (en) * 2017-02-10 2023-11-07 La Jolla Institute For Allergy And Immunology Flavivirus peptide sequences, epitopes, and methods and uses thereof
MA47515A (fr) 2017-02-16 2019-12-25 Modernatx Inc Compositions immunogènes très puissantes
EP3681514A4 (en) 2017-09-14 2021-07-14 ModernaTX, Inc. RNA VACZINE AGAINST ZIKA VIRUS
MY202505A (en) 2017-11-03 2024-05-01 Takeda Vaccines Inc Zika vaccines and immunogenic compositions, and methods of using the same
SG11202003975WA (en) 2017-11-30 2020-06-29 Takeda Vaccines Inc Method for inactivating zika virus and related methods
US11491217B2 (en) 2017-12-06 2022-11-08 Emory University Chimeric viruses encoding mutant zika virus envelope glycoproteins
US11738079B2 (en) 2018-07-23 2023-08-29 The University Of Adelaide Zika virus vaccine
WO2020092564A1 (en) * 2018-10-31 2020-05-07 Icahn School Of Medicine At Mount Sinai Human antibodies targeting zika virus ns1, ns1 polypeptides and uses thereof
MA55321A (fr) 2019-03-15 2022-01-19 Modernatx Inc Vaccins à base d'arn contre le vih
KR102553857B1 (ko) * 2021-02-05 2023-07-17 에스티팜 주식회사 신규 핵산 분자

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000014245A1 (en) * 1998-09-02 2000-03-16 The Government Of The United States Of America Represented By The Secretary, Department Of Health And Human Services Dengue viruses that are replication defective in mosquitos for use as vaccines
CA2646623A1 (en) 2005-12-14 2007-08-23 The Board Of Regents Of The University Of Oklahoma Rna virus vaccines and methods
JP5788676B2 (ja) * 2008-01-11 2015-10-07 イノビオ ファーマシューティカルズ,インコーポレイティド デングウイルスの複数のサブタイプに対する新規ワクチン
CA3001374A1 (en) * 2008-11-17 2010-05-20 Vgx Pharmaceuticals, Llc Antigens that elicit immune response against flavivirus and methods of using same
KR20120093163A (ko) * 2009-09-14 2012-08-22 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 Il-15 수용체 알파 및/또는 이를 인코딩하는 핵산 분자를 포함하는 백신 및 면역 치료제, 및 이를 이용하는 방법
BR112012010357B1 (pt) * 2009-11-02 2022-05-24 Inovio Pharmaceuticals, Inc. Proteínas de consenso de vírus de doença de febre aftosa (fmdv), sequências de codificação para as mesmas e vacinas feitas a partir das mesmas
US8691961B1 (en) * 2009-11-09 2014-04-08 Integral Molecular, Inc. Flavivirus reporter virus and methods of making and using the same
WO2011115583A1 (en) * 2010-03-19 2011-09-22 National University Of Singapore A novel platform for retrovirus-like particle (vlp)-display of vaccine antigens
BR112012024224A2 (pt) * 2010-03-24 2016-11-29 Arbovax Inc mutações da faixa de hospedeiro de flavivírus e seu uso.
CN103476928B (zh) * 2010-12-09 2017-03-29 巴斯德研究所 用于获得高产量重组蛋白表达的基于mgmt的方法
CA2826199A1 (en) 2011-01-31 2012-08-09 The Trustees Of The University Of Pennsylvania Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the same, and methods of use thereof
EP2788478B1 (en) 2011-12-09 2017-08-23 Institut Pasteur Multiplex immuno screening assay
US9987347B2 (en) * 2013-03-15 2018-06-05 The Trustees Of The University Of Pennsylvania Vaccines against multiple subtypes of dengue virus
CA2992531C (en) 2015-07-16 2023-09-26 Bharat Biotech International Limited Vaccine compositions
MA42502A (fr) 2015-07-21 2018-05-30 Modernatx Inc Vaccins contre une maladie infectieuse
WO2017070624A1 (en) * 2015-10-22 2017-04-27 Modernatx, Inc. Tropical disease vaccines
WO2017140905A1 (en) * 2016-02-17 2017-08-24 Curevac Ag Zika virus vaccine
KR20190003471A (ko) * 2016-02-25 2019-01-09 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 지카 바이러스에 대항하는 신규한 백신
MX2019000725A (es) * 2016-07-18 2019-07-04 Variation Biotechnologies Inc Composiciones de vacuna para tratamiento de virus zika.
KR102668318B1 (ko) * 2016-09-19 2024-05-22 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 지카바이러스에 대항하는 신규한 백신 및 지카바이러스에 대해 사용하기 위한 dna 항체 작제물의 조합
EP3568155A4 (en) * 2017-01-11 2020-09-23 The Trustees Of The University Of Pennsylvania RNA MODIFIED BY NUCLEOSIDE TO INDUCE AN IMMUNE RESPONSE AGAINST ZIKA VIRUS
EP3412307A1 (en) * 2017-06-07 2018-12-12 Institut Pasteur Recombinant measles virus expressing zika virus proteins and their applications

Similar Documents

Publication Publication Date Title
US12239699B2 (en) Immunogen for broad-spectrum influenza vaccine and application thereof
Zens et al. Memory CD4 T cells in influenza
JP6333730B2 (ja) 改善されたil−12遺伝子構築物を含む組成物、及びそれを用いたワクチン、免疫治療剤及び方法
JP2015501656A5 (enExample)
JP2012515557A5 (enExample)
JP2014534202A5 (enExample)
RU2677799C2 (ru) Модифицированные суперспиральные белки с улучшенными свойствами
FI3872085T3 (fi) Esimuotoiset virussekvenssit ja niiden käytöt
JP2014507146A5 (enExample)
JP2010516290A5 (enExample)
JP2009540801A5 (enExample)
JP2015501840A5 (enExample)
JP2009544333A5 (enExample)
JP2013507907A5 (enExample)
JP2016517414A (ja) インフルエンザ核酸分子及びそれから作製したワクチン
JP2013515747A5 (enExample)
JP2006514549A5 (enExample)
JP2011517938A5 (enExample)
WO2022071513A1 (ja) SARS-CoV-2に対する改良型DNAワクチン
CN103467571A (zh) 一种畜禽免疫增强剂法氏囊多肽
KR20180064158A (ko) 구제역 바이러스의 가용성 다가 항원단백질 및 이의 용도
CN106282178A (zh) 重组嗜酸乳杆菌s层蛋白在大肠杆菌中的高效表达及其应用
JP2013504600A5 (enExample)
CN103173455B (zh) 一种具有抗新城疫病毒活性的鹅源基因rig-i及其应用
JP2013545735A (ja) インフルエンザウィルスの組換えヘマグルチニン蛋白質及びそれを含むワクチン